Alterity Therapeutics Limited
PRNAF
$0.0101
$0.0065180.56%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.81M | 3.15M | 8.43M | 8.24M | 8.40M |
| Total Receivables | 3.52M | 3.94M | 2.70M | 2.64M | 4.08M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 1.55M | 1.51M | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 130.30K | 146.00K | 27.10K | 26.50K | 2.51M |
| Total Current Assets | 6.46M | 7.23M | 12.70M | 12.41M | 14.99M |
|
|
|||||
| Total Current Assets | 6.46M | 7.23M | 12.70M | 12.41M | 14.99M |
| Net Property, Plant & Equipment | 71.60K | 80.30K | 124.70K | 121.90K | 136.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.53M | 7.31M | 12.83M | 12.54M | 15.13M |
|
|
|||||
| Total Accounts Payable | 1.27M | 1.42M | 387.70K | 379.00K | 2.48M |
| Total Accrued Expenses | 363.20K | 407.00K | 3.04M | 2.97M | 446.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.80K | 43.50K | 71.50K | 69.90K | 122.10K |
| Total Finance Division Other Current Liabilities | 10.70K | 12.00K | 87.00K | 85.10K | 18.50K |
| Total Other Current Liabilities | 10.70K | 12.00K | 87.00K | 85.10K | 18.50K |
| Total Current Liabilities | 1.68M | 1.88M | 3.59M | 3.50M | 3.06M |
|
|
|||||
| Total Current Liabilities | 1.68M | 1.88M | 3.59M | 3.50M | 3.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 26.70K | 29.90K | 34.60K | 33.90K | 52.20K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.71M | 1.91M | 3.62M | 3.54M | 3.11M |
|
|
|||||
| Common Stock & APIC | 138.33M | 154.97M | 148.89M | 145.52M | 146.54M |
| Retained Earnings | -136.77M | -153.23M | -142.89M | -139.66M | -137.44M |
| Treasury Stock & Other | 3.26M | 3.66M | 3.21M | 3.13M | 2.92M |
| Total Common Equity | 4.82M | 5.40M | 9.21M | 9.00M | 12.01M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.82M | 5.40M | 9.21M | 9.00M | 12.01M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.82M | 5.40M | 9.21M | 9.00M | 12.01M |
|
|
|||||
